Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carly A I Twigg

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Proteomics|October 4, 2022
Differential histone deacetylase inhibitor-induced perturbations of the global proteome landscape in the setting of high-grade serous ovarian cancerJolene M Duda, Carly A I Twigg, Stefani N Thomas
Journal of Virology|October 3, 2023
Extragenic suppression of an HSV-1 UL34 nuclear egress mutant reveals role for pUS9 as an inhibitor of epithelial cell-to-cell spreadCarly A I Twigg, Alison Haugo-Crooks, Richard J Roller
Journal of the American Society for Mass Spectrometry|December 27, 2021
Proteomic Analysis Reveals Low-Dose PARP Inhibitor-Induced Differential Protein Expression in BRCA1-Mutated High-Grade Serous Ovarian Cancer CellsJesenia M Perez, Carly A I Twigg, Weihua Guan, et al.
International Journal of Molecular Sciences|December 30, 2025
Global Proteomic Determination of the Poly-Pharmacological Effects of PARP Inhibitors Following Treatment of High-Grade Serous Ovarian Cancer CellsJesenia M Perez, Valerie Barrera-Estrada, Carly A I Twigg, et al.
Journal of Proteome Research|July 11, 2026
Protein Enrichment from Ascites Fluid Using Nanotrap Hydrogel Particle TechnologyCarly A I Twigg, Kathleen M Madden, Kristin L M Boylan, et al.
Journal of the American Society for Mass Spectrometry|September 12, 2024
Evaluation of Serum Proteome Sample Preparation Methods to Support Clinical Proteomics ApplicationsCarly A I Twigg, Jesenia M Perez, Joohyun Ryu, et al.
Clinical Proteomics|January 3, 2024
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assayJoohyun Ryu, Kristin L M Boylan, Carly A I Twigg, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Proteomics|October 4, 2022
Differential histone deacetylase inhibitor-induced perturbations of the global proteome landscape in the setting of high-grade serous ovarian cancerJolene M Duda, Carly A I Twigg, Stefani N Thomas
Journal of Virology|October 3, 2023
Extragenic suppression of an HSV-1 UL34 nuclear egress mutant reveals role for pUS9 as an inhibitor of epithelial cell-to-cell spreadCarly A I Twigg, Alison Haugo-Crooks, Richard J Roller
Journal of the American Society for Mass Spectrometry|December 27, 2021
Proteomic Analysis Reveals Low-Dose PARP Inhibitor-Induced Differential Protein Expression in BRCA1-Mutated High-Grade Serous Ovarian Cancer CellsJesenia M Perez, Carly A I Twigg, Weihua Guan, et al.
International Journal of Molecular Sciences|December 30, 2025
Global Proteomic Determination of the Poly-Pharmacological Effects of PARP Inhibitors Following Treatment of High-Grade Serous Ovarian Cancer CellsJesenia M Perez, Valerie Barrera-Estrada, Carly A I Twigg, et al.
Journal of Proteome Research|July 11, 2026
Protein Enrichment from Ascites Fluid Using Nanotrap Hydrogel Particle TechnologyCarly A I Twigg, Kathleen M Madden, Kristin L M Boylan, et al.
Journal of the American Society for Mass Spectrometry|September 12, 2024
Evaluation of Serum Proteome Sample Preparation Methods to Support Clinical Proteomics ApplicationsCarly A I Twigg, Jesenia M Perez, Joohyun Ryu, et al.
Clinical Proteomics|January 3, 2024
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assayJoohyun Ryu, Kristin L M Boylan, Carly A I Twigg, et al.
Pageof 1